DONUT Nearsightedness Study In Children and Metabolites Being Biomarkers For Glaucoma

Dr. David Berntsen (University of Houston - Houston, TX)

Dr. Pawan Singh (University of Missouri - Columbia, MO)

 Dr. David Berntsen, Clinical Sciences Department Chair and Golden-Golden Professor, College of Optometry, University of Houston, explains a clinical trial using atropine eye drops in the Delaying the Onset of Nearsightedness Until Treatment (DONUT) study.

Then, Dr. Pawan Singh, Assistant Professor of Ophthalmology, University of Missouri School of Medicine, discusses how the metabolites, agmatine and thiamine, could be biomarkers in the early diagnosis and treatment of glaucoma.

10/12/2025 Podcast (Click Image Below)

Deepeye TPS AI and Imaging for Wet AMD and Northwestern CEVO AI and Advanced Imaging for Glaucoma

Dr. Adam Dubis (University of Utah - Salt Lake City, UT)

Dr. Nicholas Volpe (Northwestern University  - Evanston, IL)

Dr. Hao Zhang (Northwestern University - Evanston, IL)

Dr. Adam Dubis, Professor of Ophthalmology and Visual Sciences, University of Utah Spencer Fox Eccles School of Medicine, John A. Moran Eye Center, explains how deepeye TPS (Therapy Planning Support) assists in personalizing treatment of the "wet" form of age-related macular degeneration.

Dr. Nicholas J. Volpe, Chair, Department of Ophthalmology, George W. and Edwina S. Tarry, Northwestern University Feinberg School of Medicine, and Dr. Hao Zhang, Professor of Biomedical Engineering, Northwestern University McCormick School of Engineering, explain how Center for Engineering in Vision and Ophthalmology (CEVO) engineers have collaborated with ophthalmologists to advance personalized glaucoma treatment with AI and high resolution imaging.

10/5/2025 Podcast (Click Image Below)